Lab Medicine Rounds

Interview with Ariela Marshall, M.D.
In this bonus episode of Lab Medicine Rounds, Dr. Ariela Marshall, Associate Professor of Medicine in the Division of Hematology at Mayo Clinic, discusses COVID-associated coagulopathy. Dr. Marshall will discuss this condition and why it’s important to recognize.

Show Notes

Time Stamps
 
00:00 Podcast Intro
 
00:40 What is COVID-associated coagulopathy and why is it important to recognize this?
 
02:45 How is this coagulopathy similar to or different from other coagulopathies that we commonly see in clinical practice?
 
04:30 Is there recommended testing for COVID-associated coagulopathy?
 
06:30 Can you explain what the soluble fibrin monomer test is?
 
08:09 How is COVID-associated coagulopathy managed in terms on prophylactic anticoagulation, therapeutic anticoagulation, and prophylactic transfusion?
 
14:23 What are a few lessons that you have learned during this pandemic so far?
 
Resources:
1.       F.A. Klok, M.J.H.A. Kruip, N.J.M. van der Meer, et al., Incidence of thrombotic complications in critically ill ICU patients with COVID-19,Thrombosis Research (2020), https://doi.org/10.1016/j.thromres.2020.04.013  
 
2.       doi:10.1111/JTH.14810 

What is Lab Medicine Rounds?

A Mayo Clinic podcast for laboratory professionals, physicians, and students, hosted by Justin Kreuter, M.D., assistant professor of laboratory medicine and pathology at Mayo Clinic, featuring educational topics and insightful takeaways to apply in your practice.